Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

In vitro activity of DS-2969b and comparator antimicrobial agents against Clostridioides (Clostridium) difficile, methicillin-resistant Staphylococcus aureus, and other anaerobic bacteria.

Tyrrell KL, Citron DM, Merriam CV, Leoncio E, Goldstein EJC.

Anaerobe. 2018 Dec;54:39-41. doi: 10.1016/j.anaerobe.2018.04.010. Epub 2018 Apr 13.

PMID:
30096588
2.

In vitro activity of eravacycline and comparator antimicrobials against 143 recent strains of Bacteroides and Parabacteroides species.

Goldstein EJC, Citron DM, Tyrrell KL.

Anaerobe. 2018 Aug;52:122-124. doi: 10.1016/j.anaerobe.2018.06.016. Epub 2018 Jul 4.

PMID:
30018028
3.
4.

Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015.

Cheknis A, Johnson S, Chesnel L, Petrella L, Sambol S, Dale SE, Nary J, Sears P, Citron DM, Goldstein EJC, Gerding DN.

Anaerobe. 2018 Oct;53:38-42. doi: 10.1016/j.anaerobe.2018.05.009. Epub 2018 May 26.

PMID:
29886050
5.

Comparative In Vitro Activity of Omadacycline against Dog and Cat Bite Wound Isolates.

Goldstein EJC, Citron DM, Tyrrell KL, Leoncio E, Merriam CV.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02551-17. doi: 10.1128/AAC.02551-17. Print 2018 Apr.

6.

Comparative In Vitro Activities of Relebactam, Imipenem, the Combination of the Two, and Six Comparator Antimicrobial Agents against 432 Strains of Anaerobic Organisms, Including Imipenem-Resistant Strains.

Goldstein EJC, Citron DM, Tyrrell KL, Leoncio E, Merriam CV.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01992-17. doi: 10.1128/AAC.01992-17. Print 2018 Feb.

7.

Corrigendum: Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibacterium rodentium.

Cox LM, Sohn J, Tyrrell KL, Citron DM, Lawson PA, Patel NB, Iizumi T, Perez-Perez GI, Goldstein EJC, Blaser MJ.

Int J Syst Evol Microbiol. 2017 Oct;67(10):4289. doi: 10.1099/ijsem.0.002339. No abstract available.

8.

In Vitro Activities of Pexiganan and 10 Comparator Antimicrobials against 502 Anaerobic Isolates Recovered from Skin and Skin Structure Infections.

Goldstein EJC, Citron DM, Tyrrell KL, Leoncio ES.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01401-17. doi: 10.1128/AAC.01401-17. Print 2017 Dec.

9.

In Vitro Activity of Pexiganan and 10 Comparator Antimicrobials against 234 Isolates, Including 93 Pasteurella Species and 50 Anaerobic Bacterial Isolates Recovered from Animal Bite Wounds.

Goldstein EJC, Citron DM, Tyrrell KL, Leoncio ES.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00246-17. doi: 10.1128/AAC.00246-17. Print 2017 Jun.

10.

Clostridium difficile Infection Among US Emergency Department Patients With Diarrhea and No Vomiting.

Abrahamian FM, Talan DA, Krishnadasan A, Citron DM, Paulick AL, Anderson LJ, Goldstein EJC, Moran GJ; EMERGEncy ID NET Study Group.

Ann Emerg Med. 2017 Jul;70(1):19-27.e4. doi: 10.1016/j.annemergmed.2016.12.013. Epub 2017 Feb 24.

PMID:
28242058
11.

Effects of control interventions on Clostridium difficile infection in England: an observational study.

Dingle KE, Didelot X, Quan TP, Eyre DW, Stoesser N, Golubchik T, Harding RM, Wilson DJ, Griffiths D, Vaughan A, Finney JM, Wyllie DH, Oakley SJ, Fawley WN, Freeman J, Morris K, Martin J, Howard P, Gorbach S, Goldstein EJC, Citron DM, Hopkins S, Hope R, Johnson AP, Wilcox MH, Peto TEA, Walker AS, Crook DW; Modernising Medical Microbiology Informatics Group.

Lancet Infect Dis. 2017 Apr;17(4):411-421. doi: 10.1016/S1473-3099(16)30514-X. Epub 2017 Jan 25.

12.

Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibaculum rodentium.

Cox LM, Sohn J, Tyrrell KL, Citron DM, Lawson PA, Patel NB, Iizumi T, Perez-Perez GI, Goldstein EJC, Blaser MJ.

Int J Syst Evol Microbiol. 2017 May;67(5):1247-1254. doi: 10.1099/ijsem.0.001793. Epub 2017 May 30. Erratum in: Int J Syst Evol Microbiol. 2017 Oct;67(10 ):4289.

13.

Response to Maja Rupnik.

Lawson PA, Citron DM, Tyrell KL, Finegold SM.

Anaerobe. 2016 Dec;42:206. doi: 10.1016/j.anaerobe.2016.10.014. Epub 2016 Nov 1. No abstract available.

PMID:
27810332
14.

Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodology.

Hastey CJ, Boyd H, Schuetz AN, Anderson K, Citron DM, Dzink-Fox J, Hackel M, Hecht DW, Jacobus NV, Jenkins SG, Karlsson M, Knapp CC, Koeth LM, Wexler H, Roe-Carpenter DE; From the Ad Hoc Working Group on Antimicrobial Susceptibility Testing of Anaerobic Bacteria of CLSI.

Anaerobe. 2016 Dec;42:27-30. doi: 10.1016/j.anaerobe.2016.07.003. Epub 2016 Jul 15.

PMID:
27427465
15.

The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.

Goldstein EJ, Citron DM, Tyrrell KL, Leoncio ES, Merriam CV.

Anaerobe. 2017 Feb;43:1-3. doi: 10.1016/j.anaerobe.2016.09.008. Epub 2016 Oct 3.

PMID:
27713022
16.

Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938.

Lawson PA, Citron DM, Tyrrell KL, Finegold SM.

Anaerobe. 2016 Aug;40:95-9. doi: 10.1016/j.anaerobe.2016.06.008. Epub 2016 Jun 28.

PMID:
27370902
17.

Ridinilazole: a novel therapy for Clostridium difficile infection.

Vickers RJ, Tillotson G, Goldstein EJ, Citron DM, Garey KW, Wilcox MH.

Int J Antimicrob Agents. 2016 Aug;48(2):137-43. doi: 10.1016/j.ijantimicag.2016.04.026. Epub 2016 May 30. Review.

18.

Comparison of the Copan eSwab System with an Agar Swab Transport System for Maintenance of Fastidious Anaerobic Bacterium Viability.

Tyrrell KL, Citron DM, Leoncio ES, Goldstein EJ.

J Clin Microbiol. 2016 May;54(5):1364-7. doi: 10.1128/JCM.03246-15. Epub 2016 Feb 17.

19.

Impact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial.

Citron DM, Tyrrell KL, Dale SE, Chesnel L, Goldstein EJ.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2069-74. doi: 10.1128/AAC.02531-15. Print 2016 Apr.

20.

Lactobacillus species: taxonomic complexity and controversial susceptibilities.

Goldstein EJ, Tyrrell KL, Citron DM.

Clin Infect Dis. 2015 May 15;60 Suppl 2:S98-107. doi: 10.1093/cid/civ072. Review.

PMID:
25922408
21.

Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strains.

Citron DM, Tyrrell KL, Goldstein EJ.

Diagn Microbiol Infect Dis. 2014 Aug;79(4):438-40. doi: 10.1016/j.diagmicrobio.2014.05.014. Epub 2014 May 20.

PMID:
24972854
22.
23.

Bacterial counts from five over-the-counter probiotics: are you getting what you paid for?

Goldstein EJ, Citron DM, Claros MC, Tyrrell KL.

Anaerobe. 2014 Feb;25:1-4. doi: 10.1016/j.anaerobe.2013.10.005. Epub 2013 Nov 1.

PMID:
24184290
24.

Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.

Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV.

Antimicrob Agents Chemother. 2013 Oct;57(10):4872-6. doi: 10.1128/AAC.01136-13. Epub 2013 Jul 22.

25.

Anaerobic and aerobic bacteriology of the saliva and gingiva from 16 captive Komodo dragons (Varanus komodoensis): new implications for the "bacteria as venom" model.

Goldstein EJ, Tyrrell KL, Citron DM, Cox CR, Recchio IM, Okimoto B, Bryja J, Fry BG.

J Zoo Wildl Med. 2013 Jun;44(2):262-72.

PMID:
23805543
26.
27.

Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections.

Claros M, Citron DM, Goldstein EJ, Merriam CV, Tyrrell KL.

Diagn Microbiol Infect Dis. 2013 Aug;76(4):546-8. doi: 10.1016/j.diagmicrobio.2013.04.025. Epub 2013 May 30.

PMID:
23727512
28.

Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.

Goldstein EJ, Citron DM, Merriam CV, Tyrrell KL.

Diagn Microbiol Infect Dis. 2013 Jul;76(3):347-51. doi: 10.1016/j.diagmicrobio.2013.03.019. Epub 2013 Apr 24.

PMID:
23623385
29.

In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.

Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV.

Antimicrob Agents Chemother. 2013 Jun;57(6):2620-30. doi: 10.1128/AAC.02418-12. Epub 2013 Mar 25.

30.

Comparative in vitro activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms.

Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV.

Antimicrob Agents Chemother. 2013 May;57(5):2401-4. doi: 10.1128/AAC.02580-12. Epub 2013 Mar 4.

31.

Ceftaroline versus isolates from animal bite wounds: comparative in vitro activities against 243 isolates, including 156 Pasteurella species isolates.

Goldstein EJ, Citron DM, Merriam CV, Tyrrell KL.

Antimicrob Agents Chemother. 2012 Dec;56(12):6319-23. doi: 10.1128/AAC.01794-12. Epub 2012 Oct 1.

32.

Antimicrobial activities of fidaxomicin.

Goldstein EJ, Babakhani F, Citron DM.

Clin Infect Dis. 2012 Aug;55 Suppl 2:S143-8. doi: 10.1093/cid/cis339.

33.

Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.

Figueroa I, Johnson S, Sambol SP, Goldstein EJ, Citron DM, Gerding DN.

Clin Infect Dis. 2012 Aug;55 Suppl 2:S104-9. doi: 10.1093/cid/cis357.

34.

MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile.

Butler MM, Shinabarger DL, Citron DM, Kelly CP, Dvoskin S, Wright GE, Feng H, Tzipori S, Bowlin TL.

Antimicrob Agents Chemother. 2012 Sep;56(9):4786-92. doi: 10.1128/AAC.00508-12. Epub 2012 Jun 25.

35.

In vitro activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic, against 377 strains of anaerobic bacteria and 34 strains of Corynebacterium species.

Tyrrell KL, Citron DM, Warren YA, Goldstein EJ.

Antimicrob Agents Chemother. 2012 Apr;56(4):2194-7. doi: 10.1128/AAC.06274-11. Epub 2012 Jan 30.

36.

Comparative in vitro activities of LFF571 against Clostridium difficile and 630 other intestinal strains of aerobic and anaerobic bacteria.

Citron DM, Tyrrell KL, Merriam CV, Goldstein EJ.

Antimicrob Agents Chemother. 2012 May;56(5):2493-503. doi: 10.1128/AAC.06305-11. Epub 2012 Jan 30.

37.

In vitro activities of CB-183,315, vancomycin, and metronidazole against 556 strains of Clostridium difficile, 445 other intestinal anaerobes, and 56 Enterobacteriaceae species.

Citron DM, Tyrrell KL, Merriam CV, Goldstein EJ.

Antimicrob Agents Chemother. 2012 Mar;56(3):1613-5. doi: 10.1128/AAC.05655-11. Epub 2011 Dec 19.

38.

Peptoniphilus coxii sp. nov. and Peptoniphilus tyrrelliae sp. nov. isolated from human clinical infections.

Citron DM, Tyrrell KL, Goldstein EJ.

Anaerobe. 2012 Apr;18(2):244-8. doi: 10.1016/j.anaerobe.2011.11.008. Epub 2011 Dec 8.

PMID:
22178538
39.

Pre-molecular identification: ignorance was bliss?

Citron DM.

Anaerobe. 2012 Apr;18(2):189-91. doi: 10.1016/j.anaerobe.2011.11.003. Epub 2011 Nov 20.

PMID:
22123075
40.

Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.

Goldstein EJ, Solomkin JS, Citron DM, Alder JD.

Clin Infect Dis. 2011 Dec;53(11):1074-80. doi: 10.1093/cid/cir664. Epub 2011 Oct 12.

PMID:
21998288
41.

Comparative susceptibilities to fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two phase III trials of fidaxomicin against Clostridium difficile infection.

Goldstein EJ, Citron DM, Sears P, Babakhani F, Sambol SP, Gerding DN.

Antimicrob Agents Chemother. 2011 Nov;55(11):5194-9. doi: 10.1128/AAC.00625-11. Epub 2011 Aug 15.

42.

Reproducibility of broth microdilution and comparison to agar dilution for testing CB-183,315 against clinical isolates of Clostridium difficile.

Citron DM, Goldstein EJ.

Diagn Microbiol Infect Dis. 2011 Aug;70(4):554-6. doi: 10.1016/j.diagmicrobio.2011.04.012.

PMID:
21767714
43.

In vitro activity of ceftazidime-NXL104 against 396 strains of beta-lactamase-producing anaerobes.

Citron DM, Tyrrell KL, Merriam V, Goldstein EJ.

Antimicrob Agents Chemother. 2011 Jul;55(7):3616-20. doi: 10.1128/AAC.01682-10. Epub 2011 May 2.

44.

Re-assessment of phenotypic identifications of Bacteroides putredinis to Alistipes species using molecular methods.

Tyrrell KL, Warren YA, Citron DM, Goldstein EJ.

Anaerobe. 2011 Jun;17(3):130-4. doi: 10.1016/j.anaerobe.2011.04.002. Epub 2011 Apr 20.

PMID:
21527349
45.

Activity of garenoxacin against 536 unusual anaerobes including 128 recovered from acute pelvic infections.

Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV.

Diagn Microbiol Infect Dis. 2011 May;70(1):131-6. doi: 10.1016/j.diagmicrobio.2010.12.006. Epub 2011 Mar 12.

PMID:
21398076
46.

Anti-anaerobic activity of serum from patients treated with tigecycline for skin/soft tissue infections.

Stein GE, Tyrrell KL, Dybas LA, Citron DM, Nicolau DP, Goldstein EJ.

Anaerobe. 2011 Aug;17(4):213-5. doi: 10.1016/j.anaerobe.2011.02.006. Epub 2011 Mar 3.

PMID:
21376823
47.

Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan.

Sherwood JE, Fraser S, Citron DM, Wexler H, Blakely G, Jobling K, Patrick S.

Anaerobe. 2011 Aug;17(4):152-5. doi: 10.1016/j.anaerobe.2011.02.007. Epub 2011 Mar 3.

PMID:
21376821
48.

Activity of Ceftaroline against Aerobic Gram-Positive and Gram-Negative Pathogens: Effect of Test Method Variability.

Citron DM, Warren YA, Tyrrell KL, Goldstein EJ.

ISRN Microbiol. 2011 Nov 17;2011:787290. doi: 10.5402/2011/787290. Print 2011.

49.

Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.

Appleman MD, Citron DM.

Diagn Microbiol Infect Dis. 2010 Apr;66(4):441-4. doi: 10.1016/j.diagmicrobio.2009.11.008.

PMID:
20226335
50.

In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria.

Citron DM, Tyrrell KL, Merriam CV, Goldstein EJ.

Antimicrob Agents Chemother. 2010 Apr;54(4):1627-32. doi: 10.1128/AAC.01788-09. Epub 2010 Jan 25.

Supplemental Content

Loading ...
Support Center